TOX-96 Report Series: NTP Toxicity Report Series Report Series Number: 96 Official Citation: National Toxicology Program (NTP)
Total Page:16
File Type:pdf, Size:1020Kb
NTP TECHNICAL REPORT ON THE TOXICITY STUDIES OF PERFLUOROALKYL SULFONATES (PERFLUOROBUTANE SULFONIC ACID, PERFLUOROHEXANE SULFONATE POTASSIUM SALT, AND PERFLUOROOCTANE SULFONIC ACID) ADMINISTERED BY GAVAGE TO SPRAGUE DAWLEY (HSD :S PRAGUE D AWLEY SD) R ATS NTP TOX 96 AUGUST 2019 NTP Technical Report on the Toxicity Studies of Perfluoroalkyl Sulfonates (Perfluorobutane Sulfonic Acid, Perfluorohexane Sulfonate Potassium Salt, and Perfluorooctane Sulfonic Acid) Administered by Gavage to Sprague Dawley (Hsd:Sprague Dawley SD) Rats Toxicity Report 96 August 2019 National Toxicology Program Public Health Service U.S. Department of Health and Human Services ISSN: 2378-8992 Research Triangle Park, North Carolina, USA Perfluoroalkyl Sulfonates, NTP TOX 96 Foreword The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Toxicity Study Report series began in 1991. The studies described in the Toxicity Study Report series are designed and conducted to characterize and evaluate the toxicologic potential of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in the Toxicity Study Reports are based only on the results of these NTP studies. Extrapolation of these results to other species, including characterization of hazards and risks to humans, requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s toxic potential. The NTP conducts its studies in compliance with its laboratory health and safety guidelines and FDA Good Laboratory Practice Regulations and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. NTP Toxicity Study Reports are indexed in National Center for Biotechnology Information (NCBI) Bookshelf and are available free of charge electronically on the NTP website (http://ntp.niehs.nih.gov). Additional information regarding this study may be requested through Central Data Management (CDM) at [email protected]. Toxicity data are available through NTP’s Chemical Effects in Biological Systems (CEBS) database. ii Perfluoroalkyl Sulfonates, NTP TOX 96 Table of Contents Foreword ......................................................................................................................................... ii Tables ............................................................................................................................................. iv Figures............................................................................................................................................ vi About This Report........................................................................................................................ viii Peer Review .................................................................................................................................. xii Publication Details ....................................................................................................................... xiii Abstract ........................................................................................................................................ xiv Overview ...................................................................................................................................... xix Introduction ......................................................................................................................................1 Chemical and Physical Properties ...............................................................................................1 Production, Use, and Human Exposure ......................................................................................1 Regulatory Status ........................................................................................................................2 Absorption, Distribution, Metabolism, Excretion, and Toxicokinetics ......................................3 Toxicity .......................................................................................................................................4 Experimental Animals .........................................................................................................4 Humans ................................................................................................................................5 Carcinogenicity ...........................................................................................................................5 Experimental Animals .........................................................................................................5 Humans ................................................................................................................................5 Genetic Toxicity ..........................................................................................................................5 Study Rationale ...........................................................................................................................6 Materials and Methods .....................................................................................................................7 Procurement and Characterization ..............................................................................................7 Perfluoroalkyl Sulfonates.....................................................................................................7 Wyeth-14,643.......................................................................................................................8 Tween® 80 ............................................................................................................................8 Preparation and Analysis of Dose Formulations .........................................................................8 Animal Source .............................................................................................................................9 Animal Welfare ...........................................................................................................................9 28-day Studies ...........................................................................................................................10 Statistical Methods ....................................................................................................................16 Calculation and Analysis of Lesion Incidences .................................................................16 Analysis of Continuous Variables .....................................................................................16 Quality Assurance Methods ......................................................................................................16 Genetic Toxicology ...................................................................................................................17 Bacterial Mutagenicity Test Protocol ................................................................................17 Rat Peripheral Blood Micronucleus Test Protocol ............................................................17 Evaluation Protocol ............................................................................................................18 Results ............................................................................................................................................19 28-day Studies ...........................................................................................................................19 iii Perfluoroalkyl Sulfonates, NTP TOX 96 Perfluorobutane Sulfonic Acid (PFBS) .............................................................................19 Perfluorohexane Sulfonate Potassium Salt (PFHxSK) ......................................................34 Perfluorooctane Sulfonic Acid (PFOS) .............................................................................43 Wyeth-14,643.....................................................................................................................55 Histopathologic Descriptions .............................................................................................62 Genetic Toxicology ...................................................................................................................64 Discussion